Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KEYS
|
Jo Ann Juskie
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 2,982 Added 24.03% |
-
|
Oct 17
2025 |
|
SION
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect | 61,124 Reduced 0.0% |
$2,002,422
$32.76 p/Share
|
Oct 17
2025 |
|
NVDA
|
Jen Hsun Huang
President and CEO |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 0.11% |
$13,677,750
$182.37 p/Share
|
Oct 17
2025 |
|
MARA
|
Frederick G Thiel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,505 Reduced 0.73% |
$538,272
$19.57 p/Share
|
Oct 17
2025 |
|
IGC
|
Ram Mukunda
CEO |
SELL
Bona fide gift
|
Direct | 100,000 Reduced 2.44% |
-
|
Oct 17
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 131,680 Reduced 0.4% |
$55,305
$0.42 p/Share
|
Oct 17
2025 |
|
BYSI
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P. |
SELL
Open market or private sale
|
Indirect | 45,513 Reduced 0.0% |
$80,102
$1.76 p/Share
|
Oct 17
2025 |
|
GH
|
Medina Manuel Hidalgo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 232 Added 15.0% |
-
|
Oct 17
2025 |
|
GH
|
Myrtle S Potter
Director |
SELL
Open market or private sale
|
Direct | 26 Reduced 0.14% |
$1,740
$66.95 p/Share
|
Oct 17
2025 |
|
GH
|
Musa Tariq
Director |
SELL
Open market or private sale
|
Direct | 116 Reduced 1.48% |
$7,766
$66.95 p/Share
|
Oct 17
2025 |
|
GBX
|
Lorie Tekorius
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 3,506 Reduced 1.33% |
$159,417
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Matthew Joseph Meyer
SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 310 Reduced 4.83% |
$14,095
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Christian Lucky
SVP, CLO and CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 504 Reduced 4.34% |
$22,916
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
William J. Krueger
SVP, COO, The Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 1,020 Reduced 3.12% |
$46,379
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
William Glenn
SVP & President, Europe |
SELL
Exercise of conversion of derivative security
|
Direct | 2,701 Reduced 8.93% |
-
|
Oct 17
2025 |
|
GBX
|
Laurie R Dornan
SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 483 Reduced 1.6% |
$21,962
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Michael J Donfris
SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 724 Reduced 4.25% |
$32,920
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Brian J Comstock
EVP & President, The Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 1,666 Reduced 4.62% |
$75,753
$45.47 p/Share
|
Oct 17
2025 |
|
PRTS
|
Ryan Lockwood
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,709 Reduced 3.12% |
$4,427
$0.66 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
SELL
Open market or private sale
|
Direct | 21,721 Reduced 67.08% |
$4,185,853
$192.71 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
BUY
Exercise of conversion of derivative security
|
Direct | 21,721 Added 40.15% |
$3,430,180
$157.92 p/Share
|
Oct 17
2025 |
|
PRTS
|
David Meniane
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 22,217 Reduced 1.19% |
$14,663
$0.66 p/Share
|
Oct 17
2025 |
|
LVTX
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct | 1,181,131 Reduced 28.61% |
$1,736,262
$1.47 p/Share
|
Oct 17
2025 |
|
RMI
|
River North Financial Holdings, LLC |
BUY
Open market or private purchase
|
Direct | 4,138 Added 23.51% |
$60,497
$14.62 p/Share
|
Oct 17
2025 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 596,356 Reduced 0.0% |
$3,202,431
$5.37 p/Share
|
Oct 17
2025 |
|
DC
|
Stephen T. O'Rourke
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 4.91% |
$238,499
$4.77 p/Share
|
Oct 17
2025 |
|
SHLS
|
Dominic Bardos
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,758 Reduced 0.42% |
$17,492
$9.95 p/Share
|
Oct 17
2025 |
|
CRSP
|
Samarth Kulkarni
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 50,895 Reduced 16.68% |
$3,456,279
$67.91 p/Share
|
Oct 17
2025 |
|
OPP
|
Stephen Andrew O'Neill |
BUY
Open market or private purchase
|
Direct | 30 Added 0.48% |
$247
$8.26 p/Share
|
Oct 17
2025 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 81,855 Added 0.0% |
$4,039,544
$49.35 p/Share
|
Oct 17
2025 |
|
OMEX
|
Mark Gordon
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 5.53% |
$105,000
$3.5 p/Share
|
Oct 17
2025 |
|
OUST
|
Megan Chung
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 5,836 Reduced 2.87% |
$181,032
$31.02 p/Share
|
Oct 17
2025 |
|
GRX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,816 Added 0.0% |
$53,507
$9.2 p/Share
|
Oct 17
2025 |
|
ESPR
|
Benjamin Looker
General Counsel |
SELL
Open market or private sale
|
Direct | 1,248 Reduced 0.32% |
$3,269
$2.62 p/Share
|
Oct 17
2025 |
|
RVMD
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 2.12% |
$11,200
$1.12 p/Share
|
Oct 17
2025 |
|
RVMD
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.16% |
$550,000
$55.0 p/Share
|
Oct 17
2025 |
|
RVMD
|
Jeff Cislini
General Counsel |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 19.22% |
$660,000
$55.0 p/Share
|
Oct 17
2025 |
|
RVMD
|
Jeff Cislini
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 16.12% |
$438,840
$36.57 p/Share
|
Oct 17
2025 |
|
JAMF
|
John Strosahl
CEO |
SELL
Open market or private sale
|
Direct | 43,650 Reduced 2.86% |
$431,262
$9.88 p/Share
|
Oct 17
2025 |
|
SMRT
|
Daryl Stemm
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 350 Reduced 0.42% |
$511
$1.46 p/Share
|
Oct 17
2025 |
|
SMRT
|
Daryl Stemm
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 834 Added 0.99% |
-
|
Oct 17
2025 |
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 465 Reduced 0.41% |
$678
$1.46 p/Share
|
Oct 17
2025 |
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,111 Added 0.97% |
-
|
Oct 17
2025 |
|
BRT
|
Investors L P Gould |
BUY
Open market or private purchase
|
Direct | 3,953 Added 0.1% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Matthew J Gould
SENIOR VICE PRESIDENT |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Jeffrey Gould
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
MSTR
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct | 12,000 Added 29.03% |
$1,162,560
$96.88 p/Share
|
Oct 17
2025 |
|
LECO
|
Gabriel Bruno
EVP, CFO & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 261 Reduced 0.88% |
$61,340
$235.02 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 96.85% |
$1,724,720
$431.18 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 49.2% |
$481,040
$120.26 p/Share
|
Oct 17
2025 |